NCT06088082View on ClinicalTrials.gov

"Analgesic Efficacy of Combined Transversus Abdominis Plane Block and Posterior Rectus Sheath Block in Patients Undergoing Laparoscopic Appendectomy"

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

April 1, 2024

Study Completion Date

April 20, 2024

Conditions

ERAS

Interventions

DRUG

Bupivacaine Hydrochloride

Patients will be randomly assigned to receive a TAP and PRS blocks with 34 mL of 0.25% bupivacaine (study group) or standard hospital analgesia protocol (control group).

Trial Locations (1)

Unknown

Rashid Saeed Khokhar, Riyadh

All Listed Sponsors

lead

King Saud Medical City

OTHER_GOV

NCT06088082 - "Analgesic Efficacy of Combined Transversus Abdominis Plane Block and Posterior Rectus Sheath Block in Patients Undergoing Laparoscopic Appendectomy" | Biotech Hunter | Biotech Hunter